InsidersTradesSigma
유바이오로직스: directors' dealings · South Korea · DART (FSS)
DART:company-d651fbKR·DART (FSS)Mcap 413.9Bn€Healthcare
Explore the full insider trade history of 유바이오로직스, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 유바이오로직스 has published 2 public disclosures. Market capitalisation: €413.9bn. The latest transaction was reported on 3 April 2026 — Purchase. Among the most active insiders: 김락기. Every trade is free.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
11300.00 €
Analyst consensus
Income statement
Revenue149.20 Bn€
Gross profit86.20 Bn€58% margin
Net income41.26 Bn€25.9% margin
Valuation
Beta0.36
Balance sheet & cash
Market cap413.85 Bn€
Total debt4.00 Bn€
Free Cash Flow32.14 Bn€
Debt / Equity14%
Profitability & ownership
% insiders22.6%
% institutions6.4%
Last declaration on 3 April 2026